Canada Pension Plan Investment Board purchased a new position in Cabot Corporation (NYSE:CBT – Free Report) during the second quarter, Holdings Channel.com reports. The firm purchased 9,200 shares of the specialty chemicals company’s stock, valued at approximately $836,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in shares of Cabot in the second quarter worth approximately $633,302,000. Norges Bank purchased a new stake in shares of Cabot in the 4th quarter valued at approximately $49,662,000. Bank of New York Mellon Corp purchased a new stake in shares of Cabot in the 2nd quarter valued at approximately $57,445,000. AQR Capital Management LLC boosted its stake in Cabot by 123.0% in the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after purchasing an additional 478,702 shares during the period. Finally, UBS Group AG grew its position in Cabot by 186.7% during the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after purchasing an additional 386,514 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.
Insider Buying and Selling at Cabot
In other news, CEO Sean D. Keohane sold 134,895 shares of Cabot stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the completion of the sale, the chief executive officer directly owned 404,134 shares in the company, valued at $34,351,390. The trade was a 25.03% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last three months, insiders sold 229,597 shares of company stock worth $19,646,746. 3.08% of the stock is owned by company insiders.
Analyst Ratings Changes
Check Out Our Latest Report on CBT
Cabot Trading Down 1.1%
Cabot stock opened at $82.72 on Tuesday. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $94.53. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The stock has a market cap of $4.27 billion, a P/E ratio of 23.30, a P/E/G ratio of 10.98 and a beta of 0.84. The company’s fifty day simple moving average is $87.46 and its 200-day simple moving average is $81.29.
Cabot (NYSE:CBT – Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.66 by $0.01. The business had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.Cabot’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the company earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, sell-side analysts forecast that Cabot Corporation will post 6.35 EPS for the current fiscal year.
Cabot Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a dividend of $0.4725 per share. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. Cabot’s dividend payout ratio (DPR) is 53.24%.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
See Also
- Five stocks we like better than Cabot
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
